Infopshere clinical research is working with Abbott Laboratories in the enrollment of participants for the IRB-approved clinical trial investigating the efficacy of a dosage of 80mg adalimumab in the treatment of Rheumatoid arthritis.
Dr. Stephen R. White, a board certified Rheumatologist, is the primary investigator on this trial.
The researchers are studying whether the a monthly dose of adalimumab 80mg is as good as the bi-weekly dosage of 40mg.
The trial will go on for 24 weeks. A small percentage of participants will be assigned to receive a placebo for the first 12 weeks -- that's how the reseachers will learn if the drug actually works or not.
To be eligible, you must meet the following:
- Be 18 or older
- Have been diagnosed with Rheumatoid Arthritis for a minimum of three months
- Is not currently taking any medications for RA (or on a stable dose of MTX)
- Is in stable health
The deadline to apply for the trial is Oct. 31!
Call 818-222-6868 or e-mail Adrienne Scollans, patient relations, at Adrienne@infopshere.md
They are located in West Hills at 7345 Medical Center Drive, West Hills, CA 91307.
Questions or comments? Call and ask or post them here.
Published On: September 22, 2008